Cargando…
Histone Signatures Predict Therapeutic Efficacy in Breast Cancer
Objective: Regulatory abnormalities caused by chromatin modifications are being increasingly recognized as contributors to cancer. While many molecularly targeted drugs have the potential to revert these modifications, their precise mechanism of action in cellular reprogramming is not known. Methods...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
IEEE
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207876/ https://www.ncbi.nlm.nih.gov/pubmed/32412527 http://dx.doi.org/10.1109/OJEMB.2020.2967105 |
Ejemplares similares
-
Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer
por: Borkiewicz, Lidia
Publicado: (2021) -
TRIM24 links a noncanonical histone signature to breast cancer
por: Tsai, Wen-Wei, et al.
Publicado: (2010) -
Expression and potential prognostic value of histone family gene signature in breast cancer
por: Xie, Wenting, et al.
Publicado: (2019) -
A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
por: Long, Mengping, et al.
Publicado: (2021) -
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2018)